Management & Regulatory

Abzena and Argonaut Partner to Streamline Biopharma Manufacturing
Management & Regulatory Abzena and Argonaut Partner to Streamline Biopharma Manufacturing

The collaboration between Abzena and Argonaut Manufacturing Services marks a significant milestone in the biopharmaceutical industry. These two leading Contract Development and Manufacturing Organizations (CDMOs) have embarked on a strategic partnership aimed at offering comprehensive solutions for

Biopharma Faces Hurdles Despite Omnichannel Marketing Adoption
Management & Regulatory Biopharma Faces Hurdles Despite Omnichannel Marketing Adoption

Omnichannel marketing has been heralded as the next frontier in customer engagement, offering a seamless and integrated experience across various channels. The biopharmaceutical industry is no stranger to this trend, with a significant number of the top 100 pharmaceutical companies adopting

Can Biopharma Achieve Sustainability with AI and Continuous Manufacturing?
Management & Regulatory Can Biopharma Achieve Sustainability with AI and Continuous Manufacturing?

Biopharmaceuticals are in a critical transition phase where the mission to provide high-quality, effective drugs is increasingly converging with the demand for environmentally sustainable production methods. This balance requires the adoption of innovative technologies under the Industry 5.0

How Has Merck's €180M Boost Transformed Its German Hub?
Management & Regulatory How Has Merck's €180M Boost Transformed Its German Hub?

In a move that reaffirms its position as a powerhouse in the life sciences sector, Merck has made a resounding statement with a substantial €180 million investment to expand its distribution center in Schnelldorf, Germany. This ambitious project has nearly doubled the existing facility's size by an

Biopharmaceutical Industry Cuts Workforce Amid Market Shifts
Management & Regulatory Biopharmaceutical Industry Cuts Workforce Amid Market Shifts

The biopharmaceutical industry is currently experiencing a profound transformation, as companies, both large and small, are compelled to reassess their workforce levels. This sweeping realignment is a result of several factors influencing the sector, including diminished funding opportunities, the

How Will Sefia Revolutionize CAR-T Cell Therapy Production?
Management & Regulatory How Will Sefia Revolutionize CAR-T Cell Therapy Production?

The recent unveiling of the Sefia manufacturing platform by Cytiva, in partnership with Gilead Sciences’ Kite Pharma, marks a transformative step in the field of CAR-T cell therapy. With demand for these life-saving treatments increasing, the traditional production methods, fraught with manual

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later